| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |